J&J | JNJ - Sales Revenues

Stock Price
239.99
Daily Change
2.20 0.93%
Monthly
15.66%
Yearly
56.73%
Q1 Forecast
220.25

J&J reported $24.6B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Abbott USD 11.46B 90M Dec/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.19B 733M Sep/2025
Baxter International USD 2.84B 30M Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Biogen USD 2.28B 250M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
CONMED USD 373.2M 35.3M Dec/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Dexcom USD 1.21B 50M Sep/2025
Edwards Lifesciences USD 1.55B 20M Sep/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Gilead Sciences USD 7.8B 700M Sep/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Globus Medical USD 769M 23.7M Sep/2025
Hologic USD 1.05B 0 Dec/2025
Insulet USD 706.3M 57.2M Sep/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
J&J USD 24.6B 610M Dec/2025
Medtronic USD 8.96B 383M Sep/2025
Merck USD 16.4B 880M Dec/2025
Merit Medical Systems USD 384.2M 1.7M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 249.25M 8.57M Sep/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025
Vertex Pharmaceuticals USD 3.08B 120M Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025
Zoetis USD 2.4B 60M Sep/2025